CABRAL, FERNANDA V.PELEGRINO, MILENA T.SAUTER, ISMAEL P.SEABRA, AMEDEA B.CORTEZ, MAURORIBEIRO, MARTHA S.2019-12-182019-12-182019CABRAL, FERNANDA V.; PELEGRINO, MILENA T.; SAUTER, ISMAEL P.; SEABRA, AMEDEA B.; CORTEZ, MAURO; RIBEIRO, MARTHA S. Nitric oxide-loaded chitosan nanoparticles as an innovative antileishmanial platform. <b>Nitric Oxide</b>, v. 93, p. 25-33, 2019. DOI: <a href="https://dx.doi.org/10.1016/j.niox.2019.09.007">10.1016/j.niox.2019.09.007</a>. Disponível em: http://repositorio.ipen.br/handle/123456789/30458.1089-8603http://repositorio.ipen.br/handle/123456789/30458Leishmaniasis is a neglected tropical disease that demands for new therapeutic strategies due to adverse side effects and resistance development promoted by current drugs. Nitric oxide (NO)-donors show potential to kill Leishmania spp. but their use is limited because of their instability. In this work, we synthesize, characterize, and encapsulate S-nitroso-mercaptosuccinic acid into chitosan nanoparticles (NONPs) and investigate their activity on promastigotes and intracellular amastigotes of Leishmania (Leishmania) amazonensis. Cytotoxicity on macrophages was also evaluated. We verified that NONPs reduced both forms of the parasite in a single treatment. We also noticed reduction of parasitophorous vacuoles as an evidence of inhibition of parasite growth and resolution of infection. No substantial cytotoxicity was detected on macrophages. NONPs were able to provide a sustained parasite killing for both L. (L.) amazonensis infective stages with no toxicity on macrophages, representing a promising nanoplatform for cutaneous leishmaniasis.25-33openAccesschitinnanoparticlesnitric oxideprotozoaparasitic diseasesbioluminescencefluorescencemacrophagesantimitotic drugsantimicrobial agentsArtigo de periódico9310.1016/j.niox.2019.09.0070000-0002-4203-1134https://orcid.org/0000-0002-4203-113448.85567.75